As Sanofi’s Covid-19 Sales Burst Wanes, Pandemic May Become Drag

Bookmark
(Bloomberg) -- A boon to Sanofi’s profit and sales from the coronavirus outbreak will be short-lived as the pandemic hinders the drugmaker’s efforts to get some medicines to patients.
BQ Install

Bloomberg Quint

Add BloombergQuint App to Home screen.